AGP Executive Report
Last update: 12 hours agoIndia Pharmacy Crackdown: India’s chemists and druggists shut down for a one-day token strike, citing illegal online medicine sales, prescription bypassing, and predatory deep discounts—AIOCD says 12 lakh chemists backed the move and now wants authorities to act. Infection Readiness: Sentara Princess Anne Hospital in Virginia is spotlighting its Level III isolation unit, built during the 2014 Ebola outbreak, stressing it’s ready even as no confirmed cases are reported locally. New Drug Signals: FDA priority review was granted for Bayer’s Kerendia (finerenone) for adults with type 1 diabetes plus CKD, while early trial readouts include promising HIV CAR-T phase 1/2a data and ASCO 2026 reports tying GLP-1 use to lower advanced cancer risk in real-world analyses. Obesity Competition: Reuters reports lower-cost oral GLP-1s from Novo and Lilly are pulling patients away from compounded versions. Policy & Access: ICMR replaced India’s fragmented ethics approvals for multicentre studies with a single ethics review to cut delays.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
![<![CDATA[Modern Communication Between FDA, Biotech, and Investors: Q&A with David Crean]]>](https://cdn.sanity.io/images/0vv8moc6/pharmexec/395b38f139c04a5167db4f6fbdea0256ff7836fa-1920x1080.jpg)
